Carl M J Kirkpatrick Selected Research

Piperacillin

1/2022	Effect of Different Piperacillin-Tazobactam Dosage Regimens on Synergy of the Combination with Tobramycin against Pseudomonas aeruginosa for the Pharmacokinetics of Critically Ill Patients in a Dynamic Infection Model.
1/2018	Optimization and Evaluation of Piperacillin-Tobramycin Combination Dosage Regimens against Pseudomonas aeruginosa for Patients with Altered Pharmacokinetics via the Hollow-Fiber Infection Model and Mechanism-Based Modeling.
1/2016	Effect of different renal function on antibacterial effects of piperacillin against Pseudomonas aeruginosa evaluated via the hollow-fibre infection model and mechanism-based modelling.
1/2015	Are standard doses of piperacillin sufficient for critically ill patients with augmented creatinine clearance?
4/2014	Pharmacokinetics of piperacillin and tazobactam in plasma and subcutaneous interstitial fluid in critically ill patients receiving continuous venovenous haemodiafiltration.
2/2010	First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carl M J Kirkpatrick Research Topics

Disease

16	Critical Illness (Critically Ill) 01/2022 - 05/2007
11	Infections 01/2022 - 09/2007
8	Body Weight (Weight, Body) 12/2019 - 08/2007
4	AIDS-Related Complex (ARC) 12/2019 - 01/2016
3	Drug-Related Side Effects and Adverse Reactions 01/2021 - 01/2019
3	Sepsis (Septicemia) 01/2015 - 07/2009
2	Staphylococcal Infections 12/2021 - 04/2019
2	Frailty 01/2021 - 01/2016
2	Neoplasms (Cancer) 01/2018 - 07/2011
2	Inflammation (Inflammations) 12/2014 - 07/2011
2	Obesity 12/2014 - 07/2011
2	HIV Infections (HIV Infection) 10/2008 - 01/2003
2	Cystic Fibrosis (Mucoviscidosis) 04/2008 - 07/2007
1	Chronic Kidney Failure (Chronic Renal Failure) 05/2018
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Postoperative Pain 01/2018
1	Pain (Aches) 01/2018
1	Mania (Manias) 01/2017
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2017
1	Mycoses (Diseases, Fungus) 02/2016
1	Wounds and Injuries (Trauma) 05/2015
1	Cross Infection (Nosocomial Infection) 01/2015
1	Non-alcoholic Fatty Liver Disease 12/2014
1	Weight Loss (Weight Reduction) 12/2014
1	Abdominal Obesity 12/2014
1	Insulin Resistance 12/2014
1	Invasive Candidiasis 11/2014
1	Tuberculosis (Tuberculoses) 02/2013
1	Confusion (Bewilderment) 12/2012
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 07/2012
1	Chronic Disease (Chronic Diseases) 07/2011
1	Acute Kidney Injury (Acute Renal Failure) 09/2010
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 08/2007
1	Renal Cell Carcinoma (Grawitz Tumor) 08/2007
1	Hypersensitivity (Allergy) 07/2007
1	Hypoalbuminemia 06/2004
1	Rheumatoid Arthritis 01/2003
1	Heart Failure 10/2002

Drug/Important Bio-Agent (IBA)

9	Pharmaceutical PreparationsIBA 01/2021 - 01/2003
6	Piperacillin FDA LinkGeneric 01/2022 - 02/2010
5	CreatinineIBA 12/2019 - 01/2015
5	Meropenem (Merrem)FDA LinkGeneric 12/2019 - 07/2009
5	Anti-Bacterial Agents (Antibiotics)IBA 12/2019 - 07/2007
4	Tobramycin (Nebcin)FDA LinkGeneric 01/2022 - 04/2008
3	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 01/2022 - 02/2011
3	Vancomycin FDA LinkGeneric 04/2019 - 01/2012
2	Floxacillin (Flucloxacillin)IBA 12/2021 - 09/2007
2	ResveratrolIBA 12/2014 - 07/2011
2	PolyphenolsIBA 12/2014 - 07/2011
2	Tazobactam FDA LinkGeneric 04/2014 - 02/2010
1	Probenecid (Benemid)FDA LinkGeneric 12/2021
1	Carbapenems (Carbapenem Antibiotics)IBA 12/2019
1	LigandsIBA 01/2018
1	Opioid Analgesics (Opioids)IBA 01/2018
1	Toll-Like Receptor 4IBA 01/2018
1	mu Opioid Receptors (mu Opioid Receptor)IBA 01/2018
1	Opioid Receptors (Opioid Receptor)IBA 01/2018
1	Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric 07/2017
1	AS 8IBA 01/2017
1	LithiumIBA 01/2017
1	5-methoxy-methylindoleacetic acid (DBI)IBA 01/2016
1	Serum AlbuminIBA 05/2015
1	Cefazolin (Ancef)FDA LinkGeneric 05/2015
1	EnzymesIBA 12/2014
1	Triglycerides (Triacylglycerol)IBA 12/2014
1	AntioxidantsIBA 12/2014
1	Anidulafungin FDA Link 11/2014
1	Biomarkers (Surrogate Marker)IBA 02/2013
1	Ofloxacin (Ofloxacine)FDA LinkGeneric 07/2012
1	FluoroquinolonesIBA 07/2012
1	Methicillin (Metin)FDA Link 01/2012
1	ceftobiproleIBA 02/2011
1	Cefepime (Maxipime)FDA LinkGeneric 02/2011
1	Gentamicins (Gentamicin)FDA LinkGeneric 09/2010
1	Fluconazole (Zonal)FDA LinkGeneric 10/2008
1	FlavonoidsIBA 08/2007
1	Silybin (Lagosa)IBA 08/2007
1	Insulin-Like PeptidesIBA 08/2007
1	Immunoglobulin E (IgE)IBA 07/2007
1	beta Lactam AntibioticsIBA 07/2007
1	beta-LactamsIBA 07/2007
1	Cefpirome (HR 810)IBA 05/2007
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 06/2004
1	UrocortinsIBA 10/2002

Therapy/Procedure

4	Therapeutics 12/2014 - 02/2010
2	Continuous Renal Replacement Therapy 02/2015 - 04/2014
2	Critical Care (Surgical Intensive Care) 02/2010 - 07/2009
1	Polypharmacy 01/2021
1	Drug Therapy (Chemotherapy) 01/2021
1	Replacement Arthroplasty 01/2018
1	Analgesia 01/2018
1	Consolidation Chemotherapy 02/2016
1	Intravenous Infusions 01/2016
1	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2015
1	Medication Errors (Medication Error) 12/2012
1	Intranasal Administration 08/2008